{"SLR NAME":"Oral manifestations in patients with COVID-19: a living systematic review","References":[{"title1":"Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?","References":[{"title2":"Oral manifestation of Covid-19 as an inaugural symptom?","References":[]},{"title2":"High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients","References":[{"title3":"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures"},{"title3":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore"},{"title3":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study"},{"title3":"Post-infectious olfactory dysfunction exhibits a seasonal pattern"}]},{"title2":"Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine","References":[]},{"title2":"The impact of coronavirus infectious disease 19 (COVID-19) on oral health","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: Data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime"},{"title3":"Upper airway symptoms in coronavirus disease 2019 (COVID-19)"},{"title3":"Covid-19: What treatments are being investigated?"},{"title3":"COVID-19: Consider cytokine storm syndromes and immunosuppression"},{"title3":"Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic"},{"title3":"Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis"},{"title3":"Covid-19: Trials of four potential treatments to generate &quot;robust data&quot; of what works"},{"title3":"COVID-19 infection: The perspectives on immune responses"},{"title3":"COVID-19: Combining antiviral and anti-inflammatory treatments"},{"title3":"LTB4 increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"SARS-CoV-2 and COVID-19: The most important research questions"}]},{"title2":"Extensive hard palate hyperpigmentation associated with chloroquine use","References":[{"title3":"Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine"},{"title3":"Oral pigmentation: a review"},{"title3":"Of chloroquine and COVID-19"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"},{"title3":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"In vitro antiviral activity and projection of optimized dosing Design of Hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Pigmented lesions of the oral cavity: review, differential diagnosis, and case presentations"},{"title3":"Hyperpigmentation of hard palate induced by chloroquine therapy"},{"title3":"Chloroquine for the 2019 novel coronavirus SARS-CoV-2"},{"title3":"Pathological pigmentation of the skin and palate caused by continuous use of chloroquine: case report"},{"title3":"Hiperpigmentacion de la mucosa oral y discromia ungueal inducida por cloroquina"},{"title3":"Oral mucosal hyperpigmentation secondary to antimalarial drug therapy"},{"title3":"Drug-associated hyperpigmentation of the oral mucosa: report of four cases"},{"title3":"Hard palate hyperpigmentation secondary to chronic chloroquine therapy: report of five cases"},{"title3":"Pigmentation of the hard palate"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study","References":[{"title3":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study"},{"title3":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China"},{"title3":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study"}]},{"title2":"Oral vesiculobullous lesions associated with SARS-CoV-2 infection","References":[{"title3":"Coronavirus: The geriatric emergency of 2020. Joint document of the Geriatric Cardiology Section of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology"},{"title3":"Does psychosocial stress predict symptomatic herpes simplex virus recurrence? A meta-analytic investigation on prospective studies"},{"title3":"Cutaneous manifestations in COVID- 19: A new contribution"},{"title3":"Cutaneous manifestations in COVID-19: A first perspective"},{"title3":"Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine"},{"title3":"Emerging and changing viral diseases in the new millennium"},{"title3":"Strength in diversity: Understanding the pathways of HSV-1 reactivation"},{"title3":"Erythema multiforme: Recognition and management"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"}]},{"title2":"Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis","References":[]},{"title2":"Geographic tongue severity index: a new and clinical scoring system","References":[]},{"title2":"Viral exanthem with &quot;pin and needles sensation&quot; on extremities of COVID-19 patient","References":[]},{"title2":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","References":[{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability"},{"title3":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA.https://jamanetwork.com/journals/jama/fullarticle/2761044 (2020)."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. https://www.nejm.org/doi/full/10.1056/NEJMoa2001017 (2020)."},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Zou, X. et al. The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection. Front. Med. http://journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0 (2020)."},{"title3":"Zhao, Y. et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Preprint at https://www.biorxiv.org/content/10.1101/2020.01.26.919985v1 (2020)."},{"title3":"Zhang, H. et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. Preprint at https://www.biorxiv.org/content/10.1101/2020.01.30.927806v1 (2020)."},{"title3":"Chai, X. et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. Preprint at https://www.biorxiv.org/content/10.1101/2020.02.03.931766v1 (2020)."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Computational approaches for interpreting scRNA-seq data"},{"title3":"Guan, W.-J. et al. Clinical characteristics of 2019 novel coronavirus infection in China. Preprint at https://www.medrxiv.org/content/10.1101/2020.02.06.20020974v1 (2020)."},{"title3":"Asymptomatic oral human papillomavirus (HPV) infection in women with a histopathologic diagnosis of genital HPV"},{"title3":"Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory"},{"title3":"Associations between proteasomal activator PA28gamma and outcome of oral squamous cell carcinoma: evidence from cohort studies and functional analyses"},{"title3":"RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67"},{"title3":"Forrest, A. R. et al. A promoter-level mammalian expression atlas. Nature507, 462-470 (2014)."}]},{"title2":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","References":[{"title3":"WHO. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). 2020. https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (accessed Janaury 30, 2020)"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis"},{"title3":"Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures"},{"title3":"Single-cell transcriptome analysis maps the developmental track of the human heart"},{"title3":"scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation"},{"title3":"Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer"},{"title3":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations"},{"title3":"Single-cell analysis of Crohn's disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy"},{"title3":"Single-cell transcriptomics of a human kidney allograft biopsy specimen defines a diverse inflammatory response"},{"title3":"Single-cell transcriptomic map of the human and mouse bladders"},{"title3":"Dimensionality reduction for visualizing single-cell data using UMAP"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"A protein complex in the brush-border membrane explains a Hartnup disorder allele"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Myocardial infarction increases ACE2 expression in rat and humans"}]}]},{"title1":"Acute?onset smell and taste disorders in the context of COVID?19: a pilot multicentre polymerase chain reaction based case–control study","References":[{"title2":"Epidemiology of smell and taste dysfunction","References":[]},{"title2":"Treatment for smell and taste disorders: a critical review","References":[]},{"title2":"Postviral olfactory loss","References":[{"title3":"Characteristics of olfactory disorders in relation to major causes of olfactory loss"},{"title3":"Identification of viruses in patients with postviral olfactory dysfunction"},{"title3":"Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID-19): A meta-analysis of 27,492 patients"},{"title3":"Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: A study of 2579 patients"},{"title3":"Psychophysical evaluation of the olfactory function: European multicenter study on 774 COVID-19 patients"},{"title3":"Objective evaluation of anosmia and ageusia in COVID-19 patients: Single center experience on 72 cases"},{"title3":"Prevalence of olfactory dysfunction in D614G, alpha, delta and omicron waves: A psychophysical case-control study"},{"title3":"Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant"},{"title3":"Smell and taste dysfunction after COVID-19"},{"title3":"COVID-19 related persistent olfactory disorders represent an unprecedented challenge"},{"title3":"Prognosis and persistence of smell and taste dysfunction in patients with COVID-19: Meta-analysis with parametric cure modelling of recovery curves"},{"title3":"Chemosensory dysfunctions induced by COVID-19 can persist up to 7 months: A study of over 700 healthcare workers"},{"title3":"Six-month psychophysical evaluation of olfactory dysfunction in patients with COVID-19"},{"title3":"The importance of the olfactory system in human well-being, through nutrition and social behavior"},{"title3":"Impact of olfactory dysfunction on quality of life in coronavirus disease 2019 patients: A systematic review"},{"title3":"Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study"},{"title3":"New onset of smell and taste loss are common findings also in patients with symptomatic COVID-19 after complete vaccination"},{"title3":"Smell Dysfunction: A biomarker for COVID-19"},{"title3":"Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms"},{"title3":"Is loss of sense of smell a diagnostic marker in COVID-19: A systematic review and meta-analysis"},{"title3":"Self-reported olfactory loss associates with outpatient clinical course in COVID-19"},{"title3":"Self-reported olfactory loss in COVID-19: Is it really a favorable prognostic factor?"},{"title3":"Do olfactory and gustatory psychophysiocal scores have prognostic value in COVID-19 patients? A prospective study of 106 patients"},{"title3":"Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study in health workers"},{"title3":"Six-month smell and taste recovery rates in coronavirus disease 2019 patients: A prospective psychophysical study"},{"title3":"Six month follow-up of self-reported loss of smell during the COVID-19 pandemic"},{"title3":"Prevalence of persistent olfactory disorders in patients with COVID-19: A psychophysical case-control study with 1-year follow-up"},{"title3":"Self-reported smell and taste recovery in coronavirus disease 2019 patients: A one-year prospective study"},{"title3":"High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: A matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation"},{"title3":"Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study"},{"title3":"Two-year prevalence and recovery rate of altered sense of smell and taste in patients with mildly symptomatic COVID-19"},{"title3":"Parosmia assessment with structured questions and its functional impact in patients with long-term COVID-19-related olfactory dysfunction"},{"title3":"Correlations between olfactory psychophysical scores and SARS-CoV-2 viral load in COVID-19 patients"},{"title3":"Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: Is there any correlation?"},{"title3":"Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: A preliminary study"},{"title3":"Analysis of the correlations between the severity of lung involvement and olfactory and psychophysical scores in coronavirus disease 2019 (COVID-19) patients"},{"title3":"Smell and taste alterations in COVID-19: A cross-sectional analysis of different cohorts"},{"title3":"Olfactory dysfunction and sinonasal symptomatology in COVID-10: Prevalence, severity, timing, and associated characteristics"},{"title3":"Prevalence of anosmia and ageusia in patients with COVID-19 at a primary heart center, Doha, Qatar"},{"title3":"Objective olfactory findings in hospitalized severe COVID-19 patients"},{"title3":"Mood, anxiety and olfactory dysfunction in COVID-19: Evidence of central nervous system involvement?"},{"title3":"Olfactory and oral manifestations of COVID-19: Sex-related symptoms:A potential pathway to early diagnosis"},{"title3":"Study of clinical and biological characteristics of Maroccan COVID-19 patients with and without olfactory and/or gustatory dysfunction"},{"title3":"Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction"},{"title3":"The role of nasal immunoglobulins in the recovery of olfactory function in COVID-19 patients"},{"title3":"Potential pathogenesis of ageusia and anosmia in COVID-19 patients"},{"title3":"COVID-19 anosmia: High prevalence, plural neuropathogenic mechanisms, and scarce neurotropism of SARS-CoV-2?"},{"title3":"Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia"},{"title3":"COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters"},{"title3":"Clinical and radiological evaluations of COVID-19 patients with anosmia: Preliminary report"},{"title3":"ACE2 &amp; TMPRSS2 expressions in head &amp; neck tissues: A systemic review"},{"title3":"Management of new onset loss of sense of smell during the COVID-19 pandemic-BRS consensus guidelines"},{"title3":"Efficacy of corticosteroid therapy in the treatment of long-lasting olfactory disorders in COVID-19 patients"},{"title3":"Olfactory dysfunction in COVID-19: Diagnosis and management"},{"title3":"Specific therapy of olfactory disorders in COVID-19 patients is essential for the prevention of long-term dysfunction"},{"title3":"Short-term efficacy and safety of oral and nasal corticosteroids in COVID-19 patients with olfactory dysfunction: A European multicenter study"},{"title3":"The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated"},{"title3":"Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: A prospective study"},{"title3":"SARS-CoV-2 leads to significantly more severe olfactory loss than other seasonal cold viruses"},{"title3":"SARS-CoV-2 infection and taste alteration: An overview"},{"title3":"Exploring the clinical utility of gustatory dysfunction (GD) as a triage symptom prior to reverse transcription polymerase chain reaction (RT-PCR) in the diagnosis of COVID-19: A meta-analysis and systematic review"},{"title3":"Unmasking the &quot;asymptomatic&quot; COVID-19: A nose question"},{"title3":"COVID-19 smell impairment and crasstalk with hypoxia physiology"},{"title3":"Anosmia testing as early detection of SARS-CoV-2 positivity; a prospective study under screening conditions"},{"title3":"Two-year follow-up on chemosensory dysfunction and adaptive immune response after infection with SARS-CoV-2 in a cohort of 44 healthcare workers"},{"title3":"Chemosensory dysfunction in long-term COVID-19 assessed by self-reported and direct psychophysical methods"},{"title3":"The effects of persistent olfactory and gustatory dysfunctions on quality of life in long-COVID-19 patients"},{"title3":"Analysis of prevalence and predictive factors of long-lasting olfactory and gustatory dysfunction in COVID-19 patients"},{"title3":"Asthma and cacosmia could be predictive factors of olfactory dysfunction persistence 9 months after SARS-CoV-2 infection: The ANOSVID study"},{"title3":"Topical administration of mometasone is no helpful in post-COVID-19 olfactory dysfunction"},{"title3":"Gustatory and saliva secretory dysfunctions in COVID-19 patients with zinc deficiency"},{"title3":"COVID-19 and the chemical senses: Supporting players take center stage"}]},{"title2":"Identification of viruses in patients with postviral olfactory dysfunction","References":[{"title3":"Hypogeusia, dysgeusia, hyposmia, and dysosmia following influenza-like infection"},{"title3":"Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland"},{"title3":"The diagnosis of a conductive olfactory loss"},{"title3":"Patterns of non-conductive olfactory disorders in eastern Austria: a study of 120 patients from the Department of Otorhinolaryngology at the University of Vienna"},{"title3":"Clinical features of olfactory disorders in patients seeking medical consultation"},{"title3":"Anosmia and ageusia: common findings in COVID-19 patients"},{"title3":"Olfactory disorders following upper respiratory tract infections"},{"title3":"Identification of viruses in patients with postviral olfactory dysfunction"},{"title3":"Detection of parainfluenza virus 3 in turbinate epithelial cells of postviral olfactory dysfunction patients"},{"title3":"Post-infectious olfactory dysfunction exhibits a seasonal pattern"},{"title3":"An epidemiological study of postviral olfactory disorder"},{"title3":"Sniffin' Sticks: a new olfactory test battery"},{"title3":"&quot;Sniffin' sticks&quot;: screening of olfactory performance"},{"title3":"Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold"},{"title3":"Normative data for the &quot;Sniffin' sticks&quot; including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects"},{"title3":"Human rhinovirus 87 identified as human enterovirus 68 by VP4-based molecular diagnosis"},{"title3":"Detection and differentiation of picornaviruses in clinical samples following genomic amplification"},{"title3":"Parainfluenza virus type 1 infects olfactory neurons and establishes long-term persistence in the nerve tissue"},{"title3":"Sendai virus infection in the mouse brain: virus spread and long-term effects"},{"title3":"Human rhinoviruses: the cold wars resume"},{"title3":"Modulation of the immune system by human rhinoviruses"},{"title3":"Rhinoviruses in the pathogenesis of asthma: the bronchial epithelium as a major disease target"},{"title3":"Invasion and persistence of the neuroadapted influenza virus A/WSN/33 in the mouse olfactory system"},{"title3":"Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein"},{"title3":"Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan"},{"title3":"Middle East respiratory syndrome"},{"title3":"Olfactory threshold and nasal mucosal changes in experimentally induced common cold"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes"},{"title3":"The murine coronavirus as a model of trafficking and assembly of viral proteins in neural tissue"},{"title3":"Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus"},{"title3":"Comparison of three multiplex PCR assays for the detection of respiratory viral infections: evaluation of xTAG respiratory virus panel fast assay, RespiFinder 19 assay and RespiFinder SMART 22 assay"},{"title3":"Laboratory detection of respiratory viruses by automated techniques"},{"title3":"Evaluation of four commercial multiplex molecular tests for the diagnosis of acute respiratory infections"},{"title3":"Comparison of FilmArray respiratory panel and laboratory-developed real-time reverse transcription-polymerase chain reaction assays for respiratory virus detection"},{"title3":"Performance of the Luminex xTAG respiratory viral panel fast in a clinical laboratory setting"},{"title3":"Comparison of the conventional multiplex RT-PCR, real time RT-PCR and Luminex xTAG(R) RVP fast assay for the detection of respiratory viruses"},{"title3":"Comparison of the Luminex respiratory virus panel fast assay with in-house real-time PCR for respiratory viral infection diagnosis"},{"title3":"Comparison of the Luminex xTAG respiratory viral panel with in-house nucleic acid amplification tests for diagnosis of respiratory virus infections"},{"title3":"Performance of a rapid molecular multiplex assay for the detection of influenza and picornaviruses"},{"title3":"Comparison of the Luminex xTAG respiratory viral panel with xTAG respiratory viral panel fast for diagnosis of respiratory virus infections"},{"title3":"Comparison between pernasal flocked swabs and nasopharyngeal aspirates for detection of common respiratory viruses in samples from children"}]},{"title2":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","References":[]},{"title2":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study","References":[]},{"title2":"Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak","References":[{"title3":"Position paper on olfactory dysfunction"},{"title3":"Re-establishment of olfactory and taste functions"},{"title3":"Smell and taste disorders"},{"title3":"Biopsies of human olfactory epithelium"},{"title3":" World Health Organization. March 2020. "},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)"},{"title3":"Coronavirus disease 2019 (COVID-19): situation report"},{"title3":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak"},{"title3":"COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease"},{"title3":"Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study"},{"title3":"Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak"},{"title3":"Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms"},{"title3":"A primer on viral-associated olfactory loss in the era of COVID-19"},{"title3":"The use of google trends to investigate the loss of smell related searches during COVID-19 outbreak"},{"title3":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study"},{"title3":"Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection"},{"title3":"Smell dysfunction: a biomarker for COVID-19"},{"title3":"COVID-19 Anosmia Reporting Tool: Initial Findings"},{"title3":"Identification of viruses in patients with postviral olfactory dysfunction"},{"title3":"Postviral olfactory loss"},{"title3":"Postviral olfactory loss; in Seiden AM (ed): Taste and Smell Disorders"},{"title3":"Behavioural deficits and serotonin depletion in adult rats after transient infant nasal viral infection"},{"title3":"Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain"},{"title3":"Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms"}]},{"title2":"Early spread of SARS-CoV-2 in the Icelandic population","References":[]},{"title2":"COVID-19 (corona virus) and smell loss - guidance from fifth sense Medical Director, ENT UK and the British Rhinological Society. Fifth sense: smell, taste, life","References":[]},{"title2":"Recomendaciones de la Sociedad Espanola de Neurologia (SEN) en relacion con la perdida de olfato como posible sintoma precoz de infeccion por CoVID-19","References":[]},{"title2":"Investigation of chemosensitivity during and after an acute cold","References":[]}]},{"title1":"Utility of hyposmia and hypogeusia for the diagnosis of COVID-19","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Loss of sense of smell as marker of COVID-19 infection","References":[]},{"title2":"Gustatory dysfunction after mandibular zoster","References":[]},{"title2":"Taste and smell losses in HIV infected patients","References":[]},{"title2":"The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients","References":[]},{"title2":"Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study","References":[]},{"title2":"Detection of SARS-CoV-2 in different types of clinical specimens","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"Smoking upregulates angiotensin-converting enzyme-2 Receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)"},{"title3":"Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Sputum and feces after conversion of pharyngeal samples in patients with COVID-19"},{"title3":"Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study"},{"title3":"Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: elaboration and explanation"},{"title3":"An evidence-based practice guideline for the peer review of electronic search strategies"},{"title3":"PubMed, ScienceDirect, Scopus or Google Scholar:which is the best search engine for an effective literature research in laser medicine?"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of family cluster"},{"title3":"Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau"},{"title3":"Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously Xiong"},{"title3":"Meta-Analyst: software for meta-analysis of binary, continuous, and diagnostic data"},{"title3":"Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors"},{"title3":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study"}]}]},{"title1":"Mucosal involvement in a <styled-content style="fixed-case" toggle="no">COVID</styled-content>?19?positive patient: A case report","References":[{"title2":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status","References":[]},{"title2":"Comment on: cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images comment and skin biopsies","References":[{"title3":"Cutaneous manifestations in COVID-19: a first perspective"},{"title3":"The resilience of the Spanish health system against the COVID-19 pandemic"},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents"},{"title3":"Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of non-emergent dermatolgy visits"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"}]},{"title2":"Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome","References":[{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"COVID-19: a new challenge for human beings"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"COVID-19 in Europe: the Italian lesson"},{"title3":"Novel Coronavirus (2019-nCoV) situation reports [Internet]"},{"title3":"Cutaneous manifestations in COVID-19: a first perspective"},{"title3":"Dermatology staff participate in fight against Covid-19 in China"}]},{"title2":"Classification of the cutaneous manifestations of COVID19: a rapid prospective nationwide consensus study in Spain with 375 cases","References":[{"title3":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases"},{"title3":"Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients"},{"title3":"Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital"},{"title3":"Disseminated herpes simplex virus and varicella zoster virus co-infection in an immunocompetent patient"}]}]},{"title1":"Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study","References":[{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"The epidemiology, diagnosis and treatment of COVID-19","References":[{"title3":"Acute respiratory distress syndrome"},{"title3":"Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey"},{"title3":"Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis"},{"title3":"Pregnancy-related mortality resulting from influenza in the United States during the 2009-2010 pandemic"},{"title3":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States"},{"title3":"Innate immune responses to acute viral infection during pregnancy"},{"title3":"Viral infections during pregnancy"},{"title3":"The immune system in pregnancy: a unique complexity"},{"title3":"Incidence and outcomes of acute lung injury"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"Biological mechanisms of COVID-19 acute respiratory distress syndrome"},{"title3":"Acute respiratory distress syndrome in pregnancy and the puerperium: causes, courses, and outcomes"},{"title3":"Clinical characteristics and outcomes of obstetric patients requiring ICU admission"},{"title3":"Adult respiratory distress syndrome in pregnancy"},{"title3":"Maternal mortality associated with adult respiratory distress syndrome"},{"title3":"Acute respiratory distress syndrome in pregnant women"},{"title3":"2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature"},{"title3":"Human coronavirus infections and pregnancy"},{"title3":"Pregnancy outcomes among women with and without severe acute respiratory syndrome coronavirus 2 infection"},{"title3":"Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study"},{"title3":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis"},{"title3":"Are clinical outcomes worse for pregnant women at &gt;=20 weeks' gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching"},{"title3":"Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State"},{"title3":"Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, january 22-october 3, 2020"},{"title3":"Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study"},{"title3":"Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: a systematic review and meta-analysis"},{"title3":"A systematic review and meta-analysis of data on pregnant women with confirmed COVID-19: clinical presentation, and pregnancy and perinatal outcomes based on COVID-19 severity"},{"title3":"Risk factors for illness severity among pregnant women with confirmed severe acute respiratory syndrome coronavirus 2 infection-surveillance for emerging threats to mothers and babies Network, 22 state, local, and territorial health departments, 29 march 2020-5 march 2021"},{"title3":"Effect of COVID-19 on mortality of pregnant and postpartum women: a systematic review and meta-analysis"},{"title3":"Maternal COVID-19 infection, clinical characteristics, pregnancy, and neonatal outcome: a prospective cohort study"},{"title3":"COVID-19 during pregnancy: an overview of maternal characteristics, clinical symptoms, maternal and neonatal outcomes of 10,996 cases described in 15 countries"},{"title3":"The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis"},{"title3":"Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study"},{"title3":"Management and outcomes of pregnant women admitted to intensive care unit for severe pneumonia related to SARS-CoV-2 infection: the multicenter and international COVIDPREG study"},{"title3":"Association of SARS-CoV-2 infection during pregnancy with maternal and perinatal outcomes"},{"title3":"Increasing severity of COVID-19 in pregnancy with Delta (B.1.617.2) variant surge"},{"title3":"Microbial vertical transmission during human pregnancy"},{"title3":"A systematic scoping review of COVID-19 during pregnancy and childbirth"},{"title3":"An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes"},{"title3":"ACE2 expression and activity are enhanced during pregnancy"},{"title3":"Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads"},{"title3":"Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia"},{"title3":"Placental pathology in COVID-19"},{"title3":"Severity of COVID-19 in pregnancy: a review of current evidence"},{"title3":"Outcomes of neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection at a large medical center in New York city"},{"title3":"Pregnancy and COVID-19"},{"title3":"Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes"},{"title3":"Acute respiratory distress in adults"},{"title3":"Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Acute respiratory distress syndrome in pregnancy"},{"title3":"Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Early acute respiratory support for pregnant patients with coronavirus disease 2019 (COVID-19) infection"},{"title3":"Adult respiratory distress syndrome during pregnancy and immediately postpartum"},{"title3":"Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference"},{"title3":"Respiratory failure and mechanical ventilation in the pregnant patient"},{"title3":"Adult respiratory distress syndrome in pregnancy: report of three cases and review of the literature"},{"title3":"Physiologic and pharmacokinetic changes in pregnancy"},{"title3":"Dyspnea in pregnancy"},{"title3":"Respiratory and acid-base changes during pregnancy"},{"title3":"Regulation of fetoplacental vascular bed by hypoxia"},{"title3":"Fetal oxygenation and maternal ventilation"},{"title3":"Blood flow to fetal organs as a function of arterial oxygen content"},{"title3":"Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies"},{"title3":"Regulation and repair of the alveolar-capillary barrier in acute lung injury"},{"title3":"Structural alterations of lung parenchyma in the adult respiratory distress syndrome"},{"title3":"The acute respiratory distress syndrome"},{"title3":"The value of edema fluid protein measurement in patients with pulmonary edema"},{"title3":"Acute respiratory distress syndrome"},{"title3":"Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model"},{"title3":"Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs"},{"title3":"National Heart bo, and lung Institute acute respiratory distress syndrome Network: use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury"},{"title3":"Toward smarter lumping and smarter splitting: rethinking strategies for sepsis and acute respiratory distress syndrome clinical trial design"},{"title3":"Viral respiratory pathogens and lung injury"},{"title3":"Autopsy findings in COVID-19-related deaths: a literature review"},{"title3":"Pulmonary pathology of ARDS in COVID-19: a pathological review for clinicians"},{"title3":"Advanced respiratory monitoring in COVID-19 patients: use less PEEP!"},{"title3":"COVID-19 does not lead to a &quot;typical&quot; acute respiratory distress syndrome"},{"title3":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?"},{"title3":"Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study"},{"title3":"Severe covid-19 pneumonia: pathogenesis and clinical management"},{"title3":"COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS"},{"title3":"Performance of radiologists in differentiating COVID-19 from non-COVID-19 viral pneumonia at chest CT"},{"title3":"COVID-19 and Treg/Th17 imbalance: potential relationship to pregnancy outcomes"},{"title3":"Ultrafine particles in the airway aggravated experimental lung injury through impairment in Treg function"},{"title3":"Regulatory T cells and acute lung injury: cytokines, uncontrolled inflammation, and therapeutic implications"},{"title3":"The balance of the immune system between T cells and NK cells in miscarriage"},{"title3":"The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia"},{"title3":"TH17 cells in human recurrent pregnancy loss and pre-eclampsia"},{"title3":"Human seminal plasma fosters CD4(+) regulatory T-cell phenotype and transforming growth factor-beta1 expression"},{"title3":"Enhanced expression of Ang-(1-7) during pregnancy"},{"title3":"The enigma of continual plasma volume expansion in pregnancy: critical role of the renin-angiotensin-aldosterone system"},{"title3":"Angiotensin-(1-7) in normal and preeclamptic pregnancy"},{"title3":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19"},{"title3":"Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63"},{"title3":"Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility"},{"title3":"SARS-CoV-2 infection and COVID-19 during pregnancy: a multidisciplinary review"},{"title3":"Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"The complement alternative pathway and preeclampsia"},{"title3":"Complement as a target in COVID-19?"},{"title3":"Clinical trials in patients with the acute respiratory distress syndrome: burn after reading"},{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Prone positioning in severe acute respiratory distress syndrome"},{"title3":"Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury"},{"title3":"Network NARDSCT: lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury"},{"title3":"Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial"},{"title3":"Lung recruitment in patients with the acute respiratory distress syndrome"},{"title3":"The concept of &quot;baby lung&quot;"},{"title3":"Implications for the pregnant patient"},{"title3":"Putting it all together: clinical considerations in the care of critically ill obstetric patients with COVID-19"},{"title3":"Respiratory physiology of pregnancy: physiology masterclass"},{"title3":"Dyspnea in pregnancy"},{"title3":"Physiology and disease of the respiratory system in pregnancy. A review"},{"title3":"Maternal blood-gases, PAo2--Pao2), hysiological shunt and VD/VT in normal pregnancy"},{"title3":"Partial pressure of oxygen in arterial blood in normal pregnant women in Dhaka city"},{"title3":"Normative oxygen saturation values for pregnant women at sea level"},{"title3":"Guidelines for pregnancy management during the COVID-19 pandemic: a public health conundrum"},{"title3":"MFM guidance for COVID-19"},{"title3":"Physiological mechanisms of hyperventilation during human pregnancy"},{"title3":"Respiratory physiologic changes in pregnancy"},{"title3":"National Heart Ln, and Blood Institute ARDS Clinical Trials Network: higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome"},{"title3":"Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial"},{"title3":"Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial"},{"title3":"Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis"},{"title3":"Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia"},{"title3":"Positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome: the heterogeneous effects"},{"title3":"Acute respiratory failure and mechanical ventilation in women with COVID-19 during pregnancy: best clinical practices"},{"title3":"Mechanical ventilation during pregnancy"},{"title3":"Fetal outcome in the critically ill pregnant woman"},{"title3":"Current and evolving standards of care for patients with ARDS"},{"title3":"Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial"},{"title3":"Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit"},{"title3":"Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study"},{"title3":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure"},{"title3":"Noninvasive ventilatory support of patients with COVID-19 outside the intensive care units (WARd-COVID)"},{"title3":"Airway problems in pregnancy"},{"title3":"Does delivery improve maternal condition in the respiratory-compromised gravida?"},{"title3":"Mechanical ventilation to minimize progression of lung injury in acute respiratory failure"},{"title3":"Quantifying unintended exposure to high tidal volumes from breath stacking dyssynchrony in ARDS: the BREATHE criteria"},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome"},{"title3":"Clinical pharmacokinetics of neuromuscular relaxants in pregnancy"},{"title3":"Pancuronium in caesarean section and its placental transfer"},{"title3":"The placental transfer of pancuronium and its pharmacokinetics during caesarian section"},{"title3":"Pharmacokinetics, placental transfer, and neonatal effects of vecuronium and pancuronium administered during cesarean section"},{"title3":"Arthrogryposis following treatment of maternal tetanus with muscle relaxants"},{"title3":"Mechanical ventilation during pregnancy: sedation, analgesia, and paralysis"},{"title3":"ACOG practice bulletin No. 211: critical care in pregnancy"},{"title3":"Pregnancy and COVID-19: pharmacologic considerations"},{"title3":"Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure: a randomized clinical trial"},{"title3":"Prone ventilation in intubated COVID-19 patients: a systematic review and meta-analysis"},{"title3":"Prone positioning for pregnant women with hypoxemia due to coronavirus disease 2019 (COVID-19)"},{"title3":"Use of the prone position in pregnant women with COVID-19 or other health conditions"},{"title3":"The prone position in healthy pregnant women and in women with preeclampsia - a pilot study"},{"title3":"Proning modus operandi in pregnancies complicated by acute respiratory distress syndrome secondary to COVID-19"},{"title3":"Mechanical ventilation and prone positioning in pregnant patients with severe COVID-19 pneumonia: experience at a quaternary referral center"},{"title3":"National Heart ln, and blood Institute acute respiratory distress syndrome (ARDS) clinical trials Network: comparison of two fluid-management strategies in acute lung injury"},{"title3":"Respiratory disease in pregnancy"},{"title3":"Inhaled nitric oxide therapy in adults"},{"title3":"Group INOiAS: low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial"},{"title3":"High concentrations of nitric oxide inhalation therapy in pregnant patients with severe coronavirus disease 2019 (COVID-19)"},{"title3":"Inhaled nitric oxide in mechanically ventilated patients with COVID-19"},{"title3":"Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia"},{"title3":"Inhaled nitric oxide for critically ill Covid-19 patients: a prospective study"},{"title3":"Inhaled nitric oxide for primary pulmonary hypertension in pregnancy"},{"title3":"Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy"},{"title3":"Coronavirus disease 2019 (COVID-19) treatment guidelines. National institutes of health"},{"title3":"Monoclonal antibodies for treatment of SARS-CoV-2 infection during pregnancy : a cohort study"}]},{"title2":"Susceptibility of laboratory mice to intranasal and contact infection with coronaviruses of other species","References":[]},{"title2":". Neurotropism of SARS-CoV 2: mechanisms and manifestations","References":[{"title3":"The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients"},{"title3":"Neurological complications of Coronavirus disease ( COVID-19 )"},{"title3":"Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study"},{"title3":"Olfactory neuropathy in severe acute respiratory syndrome: report of a case"},{"title3":"Human respiratory coronavirus OC43: genetic stability and neuroinvasion"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain"},{"title3":"Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis"},{"title3":"Neurologic alterations due to respiratory virus infections"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43"},{"title3":"Respiratory control disorders and respiratory motor unit"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"COVID 19 and intra cerebral hemorrhage: causative or coincidental"},{"title3":"Sars-Cov-2: underestimated damage to nervous system"},{"title3":"COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features"}]},{"title2":"Dysosmia and dysgeusia due to the 2019 Novel Coronavirus; a hypothesis that needs further investigation","References":[{"title3":"Gorbalenya A (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 10.1038/s41564-020-0695-z"},{"title3":"Letko MC, Munster V (2020) Functional assessment of cell entry and receptor usage for lineage B beta-coronaviruses, including 2019-nCoV. bioRxiv"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Coronavirus infection of the central nervous system: host-virus stand-off"},{"title3":"Susceptibility of laboratory mice to intranasal and contact infection with coronaviruses of other species"},{"title3":"Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain"},{"title3":"Farda R (2020) Loss of sense of smell among Iranians coinciding with Coronavirus epidemic. Available via DIALOG. https://en.radiofarda.com/a/loss-of-sense-of-smell-among-iranians-coinciding-with-coronavirus-epidemic/30478044.html. Accessed 24 Mar 2020."},{"title3":"IFP Editorial staff (2020) Olfactory disorder getting prevalent in Iran amid Coronavirus outbreak. Available via DIALOG. https://ifpnews.com/olfactory-disorder-getting-prevalent-in-iran-amid-coronavirus. Accessed 24 Mar 2020."}]},{"title2":"Upper airway symptoms in coronavirus disease 2019 (COVID-19)","References":[{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"COVID-19 and Italy: what next?"},{"title3":"Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Chest CT findings in patients with corona virus disease 2019 and its relationship with clinical features"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study"},{"title3":"Position paper on olfactory dysfunction"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Identification of viruses in patients with postviral olfactory dysfunction"},{"title3":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms"},{"title3":"https://www.cdc.gov/coronavirus/2019-ncov/index.html. Centers for Disease Control and Prevention (CDC). 2019 Novel Coronavirus (accessed March 25th 2020)."}]},{"title2":"Characteristics of olfactory disorders in relation to major causes of olfactory loss","References":[]},{"title2":"Anosmia:a clinical review","References":[]},{"title2":"Hazardous events associated with impaired olfactory function","References":[]},{"title2":"Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study","References":[]},{"title2":"Development and validity of the DyNaChron questionnaire for chronic nasal dysfunction","References":[]},{"title2":"The number of X chromosomes influences inflammatory cytokine production following toll-like receptor stimulation","References":[{"title3":"Incidence of mortality in boys and girls after severe thermal burns"},{"title3":"Gender differences in human sepsis"},{"title3":"Gender differences in sepsis"},{"title3":"Gender differences in asthma development and progression"},{"title3":"The effect of sex on asthma control from the National Asthma Survey"},{"title3":"Gender and chronic obstructive pulmonary disease: why it matters"},{"title3":"Gender gap in cystic fibrosis mortality"},{"title3":"Gender and susceptibility to sepsis following trauma"},{"title3":"Gender differences in host defense mechanisms"},{"title3":"Gender differences in the development and function of the immune system"},{"title3":"Immunological differences in women compared with men: overview and contributing factors"},{"title3":"Sex-specific genetic architecture of human disease"},{"title3":"Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible?"},{"title3":"Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women"},{"title3":"Estrogen receptors in immunity and autoimmunity"},{"title3":"Sex hormones and the immune system-Part 1. Human data"},{"title3":"Sex hormones and the immune system-Part 2. Animal data"},{"title3":"Gender differences in inflammatory markers in children"},{"title3":"Chronic inflammatory diseases in children are more severe in girls"},{"title3":"Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay"},{"title3":"The X chromosome in immune functions: when a chromosome makes the difference"},{"title3":"The X-files of inflammation: cellular mosaicism of X-linked polymorphic genes and the female advantage in the host response to injury and infection"},{"title3":"The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases"},{"title3":"Why females are mosaics, X-chromosome inactivation, and sex differences in disease"},{"title3":"Inherent X-linked genetic variability and cellular mosaicism unique to females contribute to sex-related differences in the innate immune response"},{"title3":"X chromosome inactivation and female predisposition to autoimmunity"},{"title3":"X-inactivation profile reveals extensive variability in X-linked gene expression in females"},{"title3":"Gender differences and inflammation: an in vitro model of blood cells stimulation in prepubescent children"},{"title3":"Sex differences in inflammatory response and acid-base balance in prepubertal children with severe sepsis"},{"title3":"Gender-based differences in children with sepsis and ARDS: the ESPNIC ARDS Database Group"},{"title3":"Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers"},{"title3":"Gender difference in the non-specific and specific immune response in humans"},{"title3":"Sex differences in inflammatory cytokines and CD99 expression following in vitro lipopolysaccharide stimulation"},{"title3":"Gender difference in cytokine secretion on immune stimulation with LPS and LTA"},{"title3":"Gender difference in tumor necrosis factor-alpha production in human neutrophils stimulated by lipopolysaccharide and interferon-gamma"},{"title3":"Klinefelter syndrome:A clinical update"},{"title3":"Klinefelter syndrome (KS): genetics, clinical phenotype and hypogonadism"},{"title3":"mortality in patients with klinefelter syndrome in britain: a cohort study"},{"title3":"Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes"},{"title3":"Klinefelter's syndrome (47,XXY) among men with systemic lupus erythematosus"},{"title3":"Associations between Klinefelter's syndrome and autoimmune diseases: English national record linkage studies"},{"title3":"Klinefelter's syndrome (47,XXY) is in excess among men with Sjogren's syndrome"},{"title3":"Serum estradiol in women ingesting combination oral contraceptive steroids"},{"title3":"Hypothesis: increased male mortality caused by infection is due to a decrease in heterozygous loci as a result of a single X chromosome"},{"title3":"Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome"},{"title3":"TLR7 ligands induce higher IFN-alpha production in females"},{"title3":"Sex hormones determine immune response"},{"title3":"Ethnic and sex differences in the total and differential white cell count and platelet count"}]},{"title2":"Normative data for the &lt;&lt; Sniffin'' Sticks&quot; including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects.","References":[]},{"title2":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2","References":[]},{"title2":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2","References":[{"title3":"Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor"},{"title3":"Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism"},{"title3":"Persistent infection of SARS coronavirus in colonic cells in vitro"},{"title3":"Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Coronavirus spike proteins in viral entry and pathogenesis"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China"},{"title3":"Switching species tropism: an effective way to manipulate the feline coronavirus genome"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor"},{"title3":"Cellular entry of the SARS coronavirus"},{"title3":"SARS-associated coronavirus"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Laboratory diagonosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus"},{"title3":"Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2"},{"title3":"Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression"},{"title3":"Infectious diseases. Mounting lab accidents raise SARS fears"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The N-terminal region of the murine coronavirus spike glycoprotein is associated with the extended host range of viruses from persistently infected murine cells"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice"},{"title3":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association"},{"title3":"Evaluation of human mAb 80R in immunoprophylaxis of SARS by an animal study, epitope mapping and analysis of spike variants"},{"title3":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis"},{"title3":"Molecular constraints to interspecies transmission of viral pathogens"},{"title3":"Mice susceptible to SARS coronavirus"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys"},{"title3":"Reconstruction of the most recent common ancestor sequences of SARS-CoV S gene and detection of adaptive evolution in the spike protein"},{"title3":"Management and prevention of SARS in China"}]},{"title2":"Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations","References":[{"title3":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature10.1038/s41586-020-2012-7 (2020)."},{"title3":"Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet10.1016/S0140-6736(20)30251-8 (2020)."},{"title3":"Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Zhao, Y. et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV. bioRxiv. 10.1101/2020.01.26.919985 (2020)."},{"title3":"Rothe, C. et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N. Engl. J. Med. 10.1056/NEJMc2001468 (2020)."},{"title3":"The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans"},{"title3":"A global reference for human genetic variation"},{"title3":"Taliun, D. et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. bioRxiv10.1101/563866 (2019)."},{"title3":"Cai, G. Tobacco-use disparity in gene expression of ACE2, the receptor of 2019-nCov. Preprint at 10.20944/preprints202002.0051.v1 (2020)."},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"}]}]}]}